Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of coronary artery endothelial cells: Evidence from use of antisense LOX-1 mRNA and chemical inhibitors

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 4, 2000, Pages 1116-1122

  Li, Dayuan ^a   Mehta, Jawahar L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Endothelial cells; LOX 1; Nuclear factor B; Oxidized LDL

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN RECEPTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; ATHEROGENESIS; CORONARY ARTERY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTERNALIZATION; LIPID OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SHEAR STRESS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0034118056     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.4.1116     Document Type: Article

References (28)

1. Bickel PE, Freeman MW. Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest. 1992;90:1450-1457.
2. Kume N, Arai H, Kawai C, Kita T. Receptors for modified low density lipoproteins on human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein. Biochim Biophys Acta. 1991;1091:63-67.
3. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T. An endothelial receptor for oxidized low-density lipoprotein Nature 1997;386:73-77.
4. Kume N, Sawamura T, Moriwaki H, Itokawa S, Hoshikawa H, Aoyama A, Nishi E, Ueno Y, Masaki T, Kita T. Inducible expression of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in vascular endothelial cells. Circ Res. 1998;83:322-327.
5. Murase T, Kume N, Korenaga R, Ando J, Sawamura T, Masaki T, Kita T. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res. 1998;83: 329-333.
6. Nagase M, Hirose S, Sawamura T, Masaki T, Fujita T. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun. 1997; 237:496-498.
7. Li DY, Zhang YC, Philips MI, Sawamura T, Mehta JL. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type-1 receptor activation. Circ Res. 1999;84:1043-1049.
8. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
9. van-Boven AJ, Jukema JW, Paoletti R. Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapy. Pharmacol Res. 1994;29:261-272.
10. Nishio E, Watanabe Y. Oxysterols-induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Biochem Biophys Res Commun. 1996;226: 928-934.
11. Yang X, Galeano NF, Szabolcs M, Sciacca RR, Cannon PJ. Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis. J Nutr. 1996;126:10272s-10275s.
12. Li DY, Yang BC, Mehta JL. Ox-LDL induces apoptosis in cultured human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol. 1998;275:H568-H576.
13. Baeuerle PA. The inducible transcription activator NF-kB: regulation by distinct protein subunits. Biochem Biophys Acta. 1991;1072:63-80.
14. Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, Gerling A, Kaltschmidt C, Neumann FJ, Mackman N, Baeurele PA, Walli AK, Neumeier D. Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol. 1997;17:1901-1909.
15. Suzuki YJ, Packer L. Inhibition of NF-kappa B activation by vitamin E derivatives. Biochem Biophys Res Commun. 1993;193:277-237.
16. Hernan dez-Presa M, Bustos C, Ortego M, Renedo G, Ruiz-Ortega M, Egido J. Angiotensin-converting enzyme inhibitor prevents arterial nuclear factor-kB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation. 1997;95:1532-1541.
17. DeMeester SL, Buchman TG, Qiu, Y, Jacob AK, Dunnigan K, Hotchkiss RS, Karl I, Cobb JP. Heat shock induces I kappa B-alpha and prevents stress-induced endothelial cell apoptosis. Arch Surg. 1997;132:1283-1287.
18. Wang CY, Mayo MW, Baldwin AS Jr. TNF-α and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 1996;274:784-787.
19. Maziere C, Auclair M, Djavaheri-Mergny M, Packer L, Maziere JC. Oxidized low density lipoprotein induces activation of the transcription factor NF-κB in fibroblasts, endothelial and smooth muscle cells. Biochem Mol Biol Int. 1996;39:1201-1207.
20. Mehta JL, Li DY. Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun. 1998;248:511-514.
21. Natarajan K, Singh S, Burke T Jr, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kB. Proc Natl Acad Sci U S A. 1996;93:9090-9095.
22. Li, DY, Saldeen T, Mehta JL. Gamma-tocopherol decreases ox-LDL-mediated activation of nuclear factor-κB and apoptosis in human coronary artery endothelial cells. Biochem Biophys Res Commun. 1999;259:157-161.
23. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. a mechanistic clue to the 'response to injury' hypothesis. Circulation. 1997;95:1760-1763.
24. Vieira O, Escargueil-Blanc I, Meilhac O, Basile JP, Laranjinha J, Almeida L, Salvayre R, Negre-Salvayre A. Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL. Br J Pharmacol. 1998;123:565-573.
25. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest. 1993;68:499-508.
26. Meldrum DR, Shenkar R, Sheridan BC, Cain BS, Abraham E, Harken AH. Hemorrhage activates myocardial NF-kappaB and increases TNF-alpha in the heart. J Mol Cell Cardiol. 1997;29:2849-2854.
27. Zen K, Karsan A, Stempien-Otero A, Yee E, Tupper J, Li X, Eunsn T, Kay MA, Winn RK, Harlan JM. NF-κB activation is required for human endothelial survival during exposure to tumor necrosis factor-α, but not interleukin-1β or lipopolysaccharides. J Biol Chem. 1999;274:28808-28815.
28. Chiao C, Carothers AM, Grunberger D, Solomon G, Preston GA, Barrett JC. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells. Cancer Res. 1995;55:3576-3583.